3SBio Inc. (NASDAQ: SSRX [ADR])
Shenyang, Liaoning 110027, China Phone: +86-24-2581-1820
http://www.3sbio.com
Overview
3SBio wants to find a cure for a wide spread of ailments, including cancer and viral and autoimmune diseases. The biopharmaceutical company develops protein-based products for treating diseases in nephrology, oncology, infectious diseases, and other areas through its Shenyang Sunshine subsidiary. The company's flagship product, EPIAO, is used to increase the amount of red blood cells in patients with anemia. Other products include TPIAO, which treats a chemotherapy-induced deficiency in blood platelets, and Intefen and Inleusin for leukemia, hepatitis C, and kidney and skin cancers. 3SBio sells its products primarily through distributors in China to physicians, hospitals, clinics, and dialysis centers.
Key Numbers from Hoover's UK
Key financials for 3SBio Inc. (NASDAQ: SSRX [ADR])
| Company Type | Public (NASDAQ: SSRX [ADR]) |
|---|---|
| Fiscal Year-End | December |
| 2010 Sales (mil.) | £40.9 |
| 1-Year Sales Growth | 36.5% |
| 2010 Net Income (mil.) | £7.9 |
| 1-Year Net Income Growth | 0.7% |
| 2010 Employees | 718 |
| 1-Year Employee Growth | 30.5% |
Key People from Hoover's UK
Key people and executives for 3SBio Inc. (NASDAQ: SSRX [ADR])
| Chairman | Dan Lou (Subscribers see complete biographies -- view sample)
|
|---|---|
| CEO and Director | Jing Lou |
| EVP and COO | David Chen |
Top Competitors from Hoover's UK
Top competitors of 3SBio Inc. (NASDAQ: SSRX [ADR])
There are 14 competitors for 3SBio; see more.
